Changes in Director's Interest Pursuant to Section 219 of CA 2016

05/02/2020

Changes in Director's Interest (Section 219 of CA 2016)

Amended Announcements
Please refer to the earlier announcement reference number: CS4-27052019-00002

SUNZEN BIOTECH BERHAD

Information Compiled By KLSE

Particulars of Director

Name DR FONG CHAN SENG
Descriptions(Class) Ordinary Shares

Details of changes

No
Date of change
No of securities
Type of transaction
Nature of Interest
30/05/2019
30,000
Others
Direct Interest
Name of registered holder Maybank Securities Nominees (Tempatan) Sdn. Bhd.
Description of "Others" Type of Transaction Nil
Consideration (if any)
30/05/2019
1,290
Others
Direct Interest
Name of registered holder Dr Fong Chan Seng
Description of "Others" Type of Transaction Nil
Consideration (if any)

Circumstances by reason of which change has occurred
Number of shares held as at the date of appointment as a Director of the Company
on 30 May 2019.
Nature of interest
Direct Interest

Total no of securities after change

Direct (units) 31,290
Direct (%) 0.005
Indirect/deemed interest (units) 0
Indirect/deemed interest (%) 0.000
Date of notice 30/05/2019
Date notice received by Listed Issuer 30/05/2019


Remarks :
The direct interest of Dr Fong Chan Seng should be 31,290 ordinary shares instead of 30,000 ordinary shares.


Announcement Info

Company Name SUNZEN BIOTECH BERHAD
Stock Name SUNZEN
Date Announced 05 Feb 2020
Category Changes in Director's Interest Pursuant to Section 219 of CA 2016
Reference Number CS4-05022020-00004